Insulinoma — pre-operative localization imaging
Recommended: Multiphase pancreas-protocol CT or MRI is the preferred imaging study for insulinoma — pre-operative localization imaging. After biochemical confirmation (hypoglycemia + inappropriate insulin/C-peptide on 72-h fast).
Multiphase pancreas-protocol CT or MRI
After biochemical confirmation (hypoglycemia + inappropriate insulin/C-peptide on 72-h fast). Insulinomas are typically small (< 2 cm) and hypervascular — multiphase pancreas CT (arterial + portal venous) or contrast-enhanced MRI with hepatobiliary phase. Endoscopic ultrasound (EUS) is highly sensitive for small lesions. DOTATATE PET-CT has variable sensitivity for insulinoma (lower somatostatin receptor density vs other NETs).
If the default doesn't apply
Watch-outs
Sensitivity is lower than for other pancreatic NETs (~50%) — don't rely on a negative DOTATATE to exclude insulinoma.
Look for additional pancreatic NETs, parathyroid, pituitary lesions — screen the whole syndrome.
Pearls
- Insulinomas: avidly arterial-enhancing, < 2 cm, distributed throughout pancreas.
- Arterial-phase imaging is the highest-yield single phase for detection.
- EUS sensitivity approaches 90% for head/body lesions, lower in the tail.
- Surgical cure rate > 90% for solitary insulinoma — accurate localization is the whole point.